Vir Biotechnology VIR
NASDAQ VIR
$11.13 +0.48 (+4.51%)
As of: Sep 30, 2026 · 12:05 PM EDT

Vir Biotechnology (VIR) Deferred Taxes (2018 - 2024)

Updated

Vir Biotechnology's Deferred Taxes came in at -$2.64 million for Q4 2024, compared with -$1.06 million a year earlier.

Analysis

Vir Biotechnology (VIR) Deferred Taxes (2018 - 2024) Analysis & Trends

For FY2024, Vir Biotechnology's Deferred Taxes was -$2.95 million.

  • Going back by year, Deferred Taxes was -$1.06 million in FY2023, -$15.19 million in FY2022, -$15.19 million in FY2021 and $52,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -479.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -195.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -544.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -398.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -291.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -587.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -1.32 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Vir Biotechnology 1.78 Bn 1.78 Bn 238.95 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -2.64 Mn
Sep 30, 2024 57,000.00
Dec 31, 2023 -1.06 Mn
Dec 31, 2018 980,000.00
API Access

Vir Biotechnology Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=VIR&period=max&api_key=YOUR_API_KEY